{
  "id": "9708fd7d44afd33c8b915f9c6f53a48d3f0c254d",
  "title": "EMA recommends withdrawal of marketing authorisations for levamisole medicines - European Medicines Agency",
  "summary_full": "EMA recommends withdrawal of marketing authorisations for levamisole medicines&nbsp;&nbsp;European Medicines AgencyMeeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 February 2026&nbsp;&nbsp;European Medicines AgencyEU Withdrawal of Levamisole Recommended Due to CNS Risks&nbsp;&nbsp;MedscapeEMA Recommends EU Withdrawal of Levamisole Medicines&nbsp;&nbsp;PharmTech.com",
  "summary_public": "EMA recommends withdrawal of marketing authorisations for levamisole medicines&nbsp;&nbsp;European Medicines AgencyMeeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 February 2026&nbsp;â€¦",
  "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc0wwT1FZZURQcFdFWTFpWDNyMmF0UFo5eGlhQ0JuUU1lTjl5QkJTckdWdVNyb3dqcmRkelY3bjJPMmRPVUVKaHdvLVIyU2FfM3NSdF9CUHdwQnctYU5uaWctNU1zMFRuN0gyMThkcy0tWDRHXy1vUThjSWx3OVc3Vk4zQ3lwZ0RZbEdITGN6d0FmdEVXbW1sVUR0Qm8wdjdoblpIRXJlbVI?oc=5",
  "published_at": "2026-02-13T11:29:00+00:00",
  "source": "Top stories - Google News",
  "language": "en",
  "countries_detected": [],
  "countries_scored": [],
  "sentiment_by_country": null,
  "sentiment_error": null,
  "llm_version": null,
  "llm_perspective": null,
  "llm_attempted_at": null,
  "processed_at": null
}